Advertisement
Loading...

Gelteq Limited Ordinary Shares

GELSNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.44
$-0.02(-3.43%)
U.S. Market opens in 28h 26m

Gelteq Limited Ordinary Shares (GELS) Stock Overview

Explore Gelteq Limited Ordinary Shares’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap4.3M
P/E Ratio0.00
EPS (TTM)$-0.52
ROE-0.43%
Fundamental Analysis

AI Price Forecasts

1 Month$0.99
3 Months$0.69
1 Year Target$0.00

GELS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Gelteq Limited Ordinary Shares (GELS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 33.05, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.00 and a market capitalization of 4.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.55%
5-Day Change
-2.65%
1-Month Change
-33.24%
3-Month Change
-41.22%
6-Month Change
-53.18%
Year-to-Date (YTD) Change
-41.59%
1-Year Change
-72.18%
3-Year Change
-84.11%
5-Year Change
-84.11%
All-Time (Max) Change
-84.11%

Contact Information

61 3 9087 3990
641 Glen Huntly Road, Caulfield, VIC, 3162

Company Facts

7 Employees
IPO DateOct 29, 2024
CountryAU
Actively Trading

Frequently Asked Questions